In a new study, UCSD scientists successfully designed neural precursor cells from induced pluripotent stem cells (iPSCs). Senior author Martin Marsala, MD, lauds human iPSCs as the “ultimate source of cells to be used in future clinical trials for treatment of spinal cord and central nervous system injuries in a syngeneic or allogeneic setting.”
Read the Full Article from Labroots